Heart medication converts cancer cells into vaccine
(HealthDay) -- A class of heart medications, cardiac glycosides, can induce immunogenic cell death (ICD), whereby dying cancer cells are converted into a vaccine that stimulates antitumor response, according ...
Cancer
Jul 23, 2012 |
5 / 5 (3) |
0
|
Driving developing brain neurons in the right direction
One of the marvels of brain development is the mass migration of nerve cells to their functional position. European research has investigated the molecules required for their successful navigation.
Neuroscience
Jul 16, 2012 |
not rated yet |
0
Surprising culprit behind chemo resistance in rare cancer
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Cancer
Jul 02, 2012 |
5 / 5 (3) |
0
|
HIV hides soon after infection, research shows
(Medical Xpress) -- A team of researchers led by the University of North Carolina School of Medicine has demonstrated that latency develops soon after infection and slows when antiretroviral therapy is given.
HIV & AIDS
May 30, 2012 |
3.5 / 5 (4) |
0
|
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer
May 25, 2012 |
not rated yet |
0
|
Study shows benefit of new maintenance therapy for multiple myeloma
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called ...
Cancer
May 11, 2012 |
5 / 5 (1) |
0
|
New drug shows promise for myeloma patients
(HealthDay) -- Three new studies confirm that the drug lenalidomide can significantly lengthen the time that people with multiple myeloma experience no worsening of their disease, either after having a stem ...
Cancer
May 09, 2012 |
5 / 5 (1) |
0
|
DGK-alpha helps cancer cells gain traction and mobilize
Metastasizing cancer cells often express integrins that provide better traction. A new study in The Journal of Cell Biology reveals how a lipid-converting enzyme helps the cells mobilize these integrins.
Cancer
Jan 23, 2012 |
not rated yet |
0
Notre Dame researchers report fundamental malaria discovery
A team of researchers led by Kasturi Haldar and Souvik Bhattacharjee of the University of Notre Dame's Center for Rare and Neglected Diseases has made a fundamental discovery in understanding how malaria parasites cause deadly ...
Medical research
Jan 20, 2012 |
4.8 / 5 (4) |
0
|
Towards more effective treatment for multiple myeloma
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, ...
Cancer
Jan 09, 2012 |
5 / 5 (2) |
0
|
Scientists identify an innate function of vitamin E
It's rubbed on the skin to reduce signs of aging and consumed by athletes to improve endurance but scientists now have the first evidence of one of vitamin E's normal body functions.
Medical research
Dec 20, 2011 |
4.8 / 5 (16) |
4
|
Intestine crucial to function of immune cells, research shows
Researchers at the University of Toronto have found an explanation for how the intestinal tract influences a key component of the immune system to prevent infection, offering a potential clue to the cause of autoimmune disorders ...
Medical research
Dec 12, 2011 |
5 / 5 (2) |
0
|
Researcher develops model to foster new drug development to treat pain and epilepsy
Drawing on X-ray crystallography and experimental data, as well as a software suite for predicting and designing protein structures, a UC Davis School of Medicine researcher has developed an algorithm that predicts what has ...
Medical research
Dec 12, 2011 |
not rated yet |
0
|
Researchers identify agent responsible for protection against early stages of atherosclerosis
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in ...
Cardiology
Dec 12, 2011 |
not rated yet |
0
|
Drug combination highly effective for newly diagnosed myeloma patients, study finds
(Medical Xpress) -- A three-drug combination treatment for the blood cancer multiple myeloma compares favorably to the best established therapy for newly diagnosed patients, according to a multi-center study led by Andrzej ...
Cancer
Dec 08, 2011 |
not rated yet |
0
